Holen Sie sich die Stockscreener-App
77.06
0.62%
0.445
Schlusskurs vom Vortag:
$76.61
Offen:
$76.6
24-Stunden-Volumen:
624.79K
Relative Volume:
0.43
Marktkapitalisierung:
$9.07B
Einnahmen:
$12.50B
Nettoeinkommen (Verlust:
$314.00M
KGV:
31.58
EPS:
2.44
Netto-Cashflow:
$421.00M
1W Leistung:
+1.11%
1M Leistung:
+8.27%
6M Leistung:
+8.37%
1J Leistung:
+9.17%
1-Tages-Spanne:
$76.27
$77.14
1-Wochen-Bereich:
$75.54
$77.74
52-Wochen-Spanne:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Vergleichen Sie HSIC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
77.08 | 9.02B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
811.47 | 99.55B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
340.96 | 66.53B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
199.10 | 47.15B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
AHG
Akso Health Group Adr
|
1.23 | 670.03M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-08-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Highlights and insights from Henry Schein’s new report predicting 2026 dental data - Dental Economics
How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks? - inkl
DentScribe Joins Henry Schein One API Exchange as an Authorized Integration Vendor - StreetInsider
Squarepoint Ops LLC Boosts Holdings in Henry Schein, Inc. $HSIC - MarketBeat
Top 2 Health Care Stocks That May Keep You Up At Night In December - Benzinga
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein, Inc.'s (NASDAQ:HSIC) Shareholders Might Be Looking For Exit - 富途牛牛
Westwood Holdings Group Inc. Invests $20.63 Million in Henry Schein, Inc. $HSIC - MarketBeat
Is Henry Schein Inc a good long term investmentHealthcare Stock Analysis & High Return Trading Strategies - earlytimes.in
Robert I. Schattner Oral Health Center for People with Disabilities established at Hebrew University-Hadassah School of Dental Medicine - EurekAlert!
Thompson Davis & CO. Inc. Buys Shares of 17,270 Henry Schein, Inc. $HSIC - MarketBeat
Loss Report: Will Henry Schein Inc stock benefit from infrastructure spendingOptions Play & Real-Time Sentiment Analysis - moha.gov.vn
Revenue per share of Henry Schein, Inc. – FWB:HS2 - TradingView — Track All Markets
Jim Cramer on Henry Schein: “I Think It’s a Good Stock” - MSN
Do Wall Street Analysts Like Henry Schein Stock? - MSN
Ilex Capital Partners UK LLP Takes Position in Henry Schein, Inc. $HSIC - MarketBeat
Did Henry Schein’s (HSIC) Expanded vVARDIS Deal Quietly Recast Its Minimally Invasive Dental Strategy? - simplywall.st
Henry Schein Expands Partnership with vVARDIS - Zenopa
California Public Employees Retirement System Sells 120,408 Shares of Henry Schein, Inc. $HSIC - MarketBeat
Amundi Has $14.03 Million Stock Holdings in Henry Schein, Inc. $HSIC - MarketBeat
Barclays Begins Coverage on Henry Schein (NASDAQ:HSIC) - MarketBeat
Is Henry Schein’s Streamlined Distribution Strategy Creating Value at Around $74 a Share in 2025? - simplywall.st
How Henry Schein’s (HSIC) Expanded Curodont Deal Could Reshape Its Technology-Enabled Margin Story - Yahoo Finance
Why Henry Schein (HSIC) Stock Is Up Today - The Globe and Mail
Henry Schein (HSIC) Announces Extension of Strategic Partnership Agreement - GuruFocus
Henry Schein, Inc. (HSIC): A Bull Case Theory - Finviz
Henry Schein One and AWS leverage generative AI to revolutionize dentistry - Amazon Web Services (AWS)
Henry Schein extends strategic partnership with KKR - MSN
SVB Wealth LLC Invests $1.42 Million in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein to renominate KKR designees to board for 2026 term By Investing.com - Investing.com Nigeria
Henry Schein to renominate KKR designees to board for 2026 term - Investing.com
Henry Schein Extends Strategic Partnership with KKR - TipRanks
Barclays Initiates Henry Schein With Overweight Rating, $86 Price Target - marketscreener.com
Henry Schein, Inc. $HSIC Shares Bought by Marshall Wace LLP - MarketBeat
Henry Schein Inc. stock outperforms competitors despite losses on the day - MarketWatch
Gabelli Funds LLC Sells 16,750 Shares of Henry Schein, Inc. $HSIC - MarketBeat
Resistance Check: Why Henry Schein Inc. stock remains undervaluedDollar Strength & Risk Controlled Daily Plans - BỘ NỘI VỤ
Arrowstreet Capital Limited Partnership Has $21.12 Million Holdings in Henry Schein, Inc. $HSIC - MarketBeat
409,100 Shares in Henry Schein, Inc. $HSIC Acquired by Oribel Capital Management LP - MarketBeat
Burgundy Asset Management Ltd. Sells 27,936 Shares of Henry Schein, Inc. $HSIC - MarketBeat
HSIC Stock Benefits From Expanded Partnership With vVARDIS - MSN
Stenger Family Office LLC Purchases New Stake in Henry Schein, Inc. $HSIC - MarketBeat
Invesco Ltd. Cuts Stake in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Can Make Your Portfolio Smile (NASDAQ:HSIC) - Seeking Alpha
Henry Schein (HSIC): Revisiting Valuation After Expanded vVARDIS Distribution Deal in Preventive Dentistry - Sahm
Custom Nightguards Initiated in Dentrix Now Available from Henry Schein - Dentistry Today
Norges Bank Invests $89.48 Million in Henry Schein, Inc. $HSIC - MarketBeat
2025 Healthy Outcomes Conference: Henry Schein Canada reducing disability leave claims with wellness program - Benefits Canada.com
Why Is Henry Schein (HSIC) Up 1.2% Since Last Earnings Report? - Yahoo Finance
Hsbc Holdings PLC Raises Stake in Henry Schein, Inc. $HSIC - MarketBeat
How Investors May Respond To Henry Schein (HSIC) Gaining Exclusive U.S. Rights To Drill-Free Cavity Treatment - simplywall.st
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):